Latest News
Clinical Research

Latest News First randomized, double-blind, placebo controlled study to show telomeres getting longer in humans

First randomized, double-blind, placebo controlled study to show telomeres getting longer in humans

By

This study summarizes the findings on telomere length (TL) changes from a randomized, double-blind, placebo-controlled study of TA-65® with relatively healthy cytomegalovirus-positive subjects. Subjects taking TA-65®(250 Units) significantly increased TL over a 12 month period, whereas subjects in the placebo group significantly lost TL. Changes in TL were similar for both median and 20th percentile TLs. The findings suggest that TA-65® can lengthen telomeres in a statistically and possibly clinically significant manner.

Click here to read more



Latest News New Study Observes the Impact of Telomerase Activation on Metabolic and Cardiovascular Health Markers
,

New Study Observes the Impact of Telomerase Activation on Metabolic and Cardiovascular Health Markers

By | 14th November 2013

An observational study published in the October 2013 issue of Rejuvenation Research reports on observed changes in metabolic and cardiovascular health markers in people who took TA-65MD® nutritional supplements for one year.

Check back here for more information



Latest News Functional Assessment of Pharmacological Telomerase Activators in Human T Cells

Functional Assessment of Pharmacological Telomerase Activators in Human T Cells

By

This human study demonstrates that TA-65MD® nutritional supplements increase telomerase activity and proliferation in human CD4 and CD8 T cells.

Click here to read more



Latest News A Natural Product Telomerase Activator as Part of a Health Maintenance Program

A Natural Product Telomerase Activator as Part of a Health Maintenance Program

By

Harley CB, Liu W, Blasco MA, Vera E, Andrews WH, Briggs LA, Raffaele JM. Rejuvenation Research. 2011 February; 14(1): 45—56.

This one year human study showed improvements in telomere length and immune system biomarkers for people taking TA-65® capsules.

Click here to read more



Latest News The Telomerase Activator, TA-65<sup>®</sup>, Elongates Short Telomeres and Increases Healthspan of Adult/Old Mice without Increasing Cancer Incidence

The Telomerase Activator, TA-65®, Elongates Short Telomeres and Increases Healthspan of Adult/Old Mice without Increasing Cancer Incidence

By

de Jesus BB, Schneeberger K, Vera E, Tegera A, Harley CB, Blasco MA. Aging Cell. 2011 August; 10(4): 604—621.
This animal study looked at the effects TA-65® and confirmed their mechanism of action, long-term effects, and safety.

Click here to read more



Latest News Genetic Epidemiology Research on Adult Health and Aging (GERA) Study

Genetic Epidemiology Research on Adult Health and Aging (GERA) Study

By

In the largest and most diverse study of aging to date, telomere length is being analyzed as a marker for age-related conditions. This genomic project, Genetic Epidemiology Research on Adult Health and Aging (GERA), aims to increase understanding of the genetic basis for a host of problems.

Click here to read more



Latest News The First Documented Age Reversal in a Mammal: Harvard University Study shows Telomerase Activation Helps Reverse the Aging Process

The First Documented Age Reversal in a Mammal: Harvard University Study shows Telomerase Activation Helps Reverse the Aging Process

By

Jaskelioff M., Muller F.L., Paik J.H., Thomas E., Jiang S., Adams A.C., Sahin E., Kost-Alimova M., Protopopov A., Cadiñanos J., Horner J.W., Maratos-Flier E., Depinho R.A. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 2011;469(7328):102-106.

Click here to read more



Join us on Facebook Follow us on Twitter Send TA Sciences an E-Mail
Toll-Free: 888.360.8886